Email Alert | RSS    帮助

中国防痨杂志 ›› 2021, Vol. 43 ›› Issue (4): 313-317.doi: 10.3969/j.issn.1000-6621.2021.04.003

• 专家笔谈 • 上一篇    下一篇


马艳, 高微微()   

  1. 100700 北京,中国中医科学院中医临床基础医学基础所(马艳);首都医科大学附属北京胸科医院 北京市结核病胸部肿瘤研究所 中国疾病预防控制中心结核病防治临床中心(高微微)
  • 收稿日期:2021-02-26 出版日期:2021-04-10 发布日期:2021-04-09
  • 通信作者: 高微微
  • 基金资助:

Pay attention to the reasonable treatment of retreatment tuberculosis:today is not what it used to be

MA Yan*, GAO Wei-wei()   

  1. *Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China
  • Received:2021-02-26 Online:2021-04-10 Published:2021-04-09
  • Contact: GAO Wei-wei



关键词: 结核, 再治疗, 药物疗法,联合, 方案评价


Timely and reasonable anti-tuberculosis treatment is a key measure to effectively cure tuberculosis patients, eliminate infectivity and stop the spread of the disease. The implementation of standardized retreatment regimens has played a significant role in improving the success rate of retreatment pulmonary tuberculosis patients. But Mycobacterium tuberculosis is constantly evolving, and the individual conditions of patients are also constantly changing. In addition to the current status of poor anti-tuberculosis drug treatment, the standardized retreatment regimens should be adjusted and updated accordingly. In this article, the target of retreatment pulmonary tuberculosis, the evolution of the retreatment regimens and its rational application will be discussed by the author in combination with literature and clinical experience.

Key words: Tuberculosis, Retreatment, Drug therapy, combination, Program evaluation